A Study of CS3002 in Subjects With Advanced Solid Tumors
NCT04162301
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
10
Enrollment
INDUSTRY
Sponsor class
Stopped
The study has been stopped for strategic and business reasons.
Conditions
Advanced Solid Tumor
Interventions
DRUG:
CS3002
Sponsor
CStone Pharmaceuticals